Andrew A. Krakauer, President and CEO at CANTEL MEDICAL CORP (CMN), sold 99,983 shares at $19.55 ($2.0M) on 2010-04-09, disclosed to the SEC on 2010-04-09.
Open-market sale of $2.0M CMN by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.91 | 5,020 | $100K | 5.0% |
| 2 | $19.91 | 20,437 | $407K | 20.5% |
| 3 | $19.91 | 63,021 | $1.3M | 63.1% |
| 4 | $19.56 | 5,567 | $109K | 5.5% |
| 5 | $19.58 | 1,669 | $33K | 1.6% |
| 6 | $19.59 | 2,500 |
| $49K |
| 2.5% |
| 7 | $19.75 | 1,100 | $22K | 1.1% |
| 8 | $19.55 | 669 | $13K | 0.7% |
| Total | $19.87 avg | 99,983 | $2.0M | 100% |
| Filing → |
| TFX | BUY | 2018-08-08 | $238K | — | Filing → |
| CMN | SELL | 2015-12-31 | $590K | — | Filing → |
| CMN | SELL | 2015-10-14 | $1.2M | — | Filing → |